8 midcap stocks rally up to 135% in a year; 2 turn multibaggers

Laurus Labs reported movement of 50%, 135% and -135%. Those are the figures as filed — what moves the price is how they sit against what the market already expected, not their absolute size.

Against that, the stock is +1.9% on the day at ₹2,036.60, and has returned +35.1% over three months. It is trading close to its 52-week high, so expectations were already elevated going in. The pharma & healthcare sector has moved -0.4% over the same period, so Laurus Labs is running 35.5 points ahead of its peers.

For Laurus Labs, the question is how much of this is already reflected in the price and how much re-rates the pharma & healthcare peer set alongside it.